SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: NeuroInvestment who wrote (17116)6/17/2005 6:26:25 PM
From: Jill  Respond to of 52153
 
LOL, bad joke but made me laugh. I did get to look at an alzheimer's brain and a tourette's brain. It was completely awe inspiring and terrifying.

I just think it's easier for the doctor, for whom the side effects are words on a paper, than the patient, for whom they are realities in an already tragic situation. On the other hand, your profession is not an easy one either. Still, I wonder if you looked one of them straight in the eyes with deep compassion for their struggle and acknowledged their fear as legit, whether they might come round.



To: NeuroInvestment who wrote (17116)6/17/2005 6:30:49 PM
From: Jill  Read Replies (1) | Respond to of 52153
 
P.S. I know its off topic but why do the drugs make bipolar or schiz. patients feel they have lost their personalities?

There is a major (100,000) cohort study underway now tracking pregnant women through childbirth and the first 72 months of their baby's lives; hopefully more funding will allow it to go through teenage years. They're going to try to understand more about the triggers and genetic vulnerabilities associated with autism and schizophrenia. We already know that flu outbreaks (mother getting flu) are associated. But lots of viruses like that are linked. Their thinking is that the mother's cytokine response may permanently sensitize the developing brain, and then later triggers resensitize it and push it into mental illness. This could be a good line of research with eventual new options for treatment but a long way off.